Mark R. Sullivan

Mark R. Sullivan, CMR, is a seasoned pharmaceutical professional with extensive experience in sales and account management within the healthcare industry. Currently serving as Key Account Manager for Oncology at Ferring Pharmaceuticals, Mark oversees sales efforts for a unique gene therapy in New England. Previous roles include Senior Territory Account Manager at CMP Pharma, where Mark launched a product in the Rare Disease space, and Strategic Account Manager at Medicem, Inc., focusing on high-birth-rate institutions in the Northeast. Early career achievements at Ferring Pharmaceuticals include revitalizing the Women’s Health Division and promoting various oncology products. With a strong foundation in biology from Boston College and certifications in disease state management and business, Mark has received multiple national awards and recognition for excellence in training and innovation throughout a diverse career that began at Bayer in 1982.